Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
Balzan
S
S
CNR Institute of Clinical Physiology, University of Pisa, Italy.
Montali
U
U
Biver
P
P
Ghione
S
S
D000906:Antibodies; D001798:Blood Proteins / Q000494:pharmacology*; D002298:Cardenolides; D004077:Digoxin / Q000276:immunology* / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology* / Q000378:metabolism; D006801:Humans; D010042:Ouabain / Q000494:pharmacology; D012414:Rubidium Radioisotopes / Q000493:pharmacokinetics; D012503:Saponins; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000097:blood*
D000906:Antibodies; D001798:Blood Proteins; D002298:Cardenolides; D012414:Rubidium Radioisotopes; D012503:Saponins; C034504:digoxin-like factors; D010042:Ouabain; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase